Inside the fight to include HIV-positive people in Covid-19 vaccine trials
When Jeff Taylor, a longtime AIDS advocate and survivor, learned about clinical trials for the new Covid-19 vaccine in his hometown, Palm Springs, California, he leapt at the opportunity to participate.
COVID-19 y personas que viven con el VIH Preguntas Frecuentes
Este documento fue elaborado por un grupo de organizaciones que unieron fuerzas en la creación de un recurso especializado en COVID-19 para personas que viven con el VIH, y muy atinadamente, basado en la mejor información disponible. Favor de revisar la versión más actualizada observando la fecha que aparece junto al título de este documento. Todos los días aparece más información acerca del coronavirus. Este documento se actualizará periódicamente a medida que se disponga de nueva información y recursos relevantes. Para obtener la información más actualizada o noticias, consulte en línea en vez de imprimir este documento.
The COVID-19 and People Living with HIV: Frequently Asked Question
This document was developed by a group of organizations that came together to develop a COVID-19 resource for people living with HIV based on the best information available. Please check the version date above to see when it was last updated. More information is learned nearly every day about the coronavirus. This document will be regularly updated as new information and resources become available. For the most up-to-date information, please check online rather than printing this document.
EACS & BHIVA Statement on risk of COVID-19 for people living with HIV (PLWH)
COVID-19 & HIV
Case series of HIV-patients with COVID-19 have been published from China, Spain, Germany, Italy and the United States (1-6). So far there is no clear evidence for a higher COVID-19 infection rate or different disease course in people with HIV than in HIV-negative people. Of note, most HIV case series report a younger age in their study population than in HIV-negative hospitalised COVID-19 patients but comparable rates of comorbidities. In a UK cohort study reporting outcomes on 16,749 hospitalised patients with COVID-19 only 1% involved PLWH, but HIV did not adversely impact survival .
COVID-19: Special Considerations for People with HIV
This document on special considerations for people living with HIV in light of COVID-19 is intended as a resource for clinicians and public health officials. The information is based on best practices in areas that have been heavily impacted by COVID-19, and it will be updated as more information and data become available. Please email HIVMA with suggestions or questions and visit the IDSA COVID-19 Resource Center for additional resources, including COVID-related policies and protocols developed by institutions and health systems.
Brian Risley | Manager, HIV/Hep C Health Promotion APLA Shares: Healthrisks of coronavirus for people living with HIV.
At APLA Health, we continue to monitor the latest guidance from the Los Angeles County Department of Public and the United States Centers for Disease Control and Prevention about sCOVID-19, which is caused by a novel coronavirus. Our priority is to keep you and our community safe and healthy.